GPS Wealth Strategies Group’s Dr. Reddy's Laboratories RDY Stock Holding History

GPS Wealth Strategies Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-375	Closed	-$5.92K	–	1563
2024 Q4	$5.92K	Hold	375	–	–	﹤0.01%	1060
2024 Q3	$5.96K	Hold	375	–	–	﹤0.01%	1058
2024 Q2	$5.71K	Hold	375	–	–	﹤0.01%	1040
2024 Q1	$5.5K	Hold	375	–	–	﹤0.01%	979
2023 Q4	$5.22K	Hold	375	–	–	﹤0.01%	971
2023 Q3	$5.01K	Hold	375	–	–	﹤0.01%	970
2023 Q2	$4.73K	Hold	375	–	–	﹤0.01%	998
2023 Q1	$4.27K	Buy	+375	New	+$4.05K	﹤0.01%	1003

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

GPS Wealth Strategies Group's RDY Position: Q1 2025 in Review

GPS Wealth Strategies Group sold out of Dr. Reddy's Laboratories (RDY) in Q1 2025, closing a stake of 375 shares — an estimated $5.92K sold.

GPS Wealth Strategies Group first reported a position in RDY in Q1 2023 and held it in 8 quarters. The position peaked at $5.96K in Q3 2024. 246 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

GPS Wealth Strategies Group reported no remaining Dr. Reddy's Laboratories position as of Q1 2025 after selling out during the quarter.
GPS Wealth Strategies Group sold 375 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $5.92K.
GPS Wealth Strategies Group first reported a position in Dr. Reddy's Laboratories in Q1 2023 and held it in 8 quarters.
GPS Wealth Strategies Group's Dr. Reddy's Laboratories position peaked at $5.96K in Q3 2024.
246 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q1 2025, filed 15 Apr 2025.